Explore evidence

27 participantsThe study included twenty-seven HIV+ adults classified into neurocognitive impaired (n=18) and unimpaired (n=9) groups.

NigeriaVIH/sidapublished 2023The Pan African medical journalPubMeddocument of 3 observations

0.64 %Among HIV-positive patients aged 31–40 years in the study, the prevalence of HIV/HBV/HCV triple infection was 0.64%.

Nigeriahépatite B · hépatite C · VIH/sidaobserved 2019published 2020Journal of immunoassay & immunochemistryPubMeddocument of 9 observations

54.5 %54.5% of HIV sero-positive attendees took anti-retroviral drugs (ARVs) during pregnancy.

NigeriaVIH/sidapublished 2021West African journal of medicinePubMeddocument of 4 observations

85 daysMedian time to death was 85 days in HIV-uninfected subjects.

Nigeriacarcinome hépatocellulaire · VIH/sidapublished 2021Tropical medicine & international health : TM & IHPubMeddocument of 15 observations

32 %Of the 573,630 ART clients analysed in this study, 32% have been recorded as having interrupted treatment.

NigeriaVIH/sidaobserved 2000-2020published 2021BMC public healthPubMeddocument of 12 observations

48.8 %39 (48.8%) of the youth preferred blood-based HIV self-testing.

NigeriaVIH/sidapublished 2019BMC health services researchPubMeddocument of 5 observations

1,419 US_dollar_per_patient_with_undetectable_viral_loadThe incentive scheme intervention achieved an incremental cost-effectiveness ratio of US$1419 per additional patient with undetectable viral load compared to routine care.

NigeriaVIH/sidapublished 2021BMC health services researchPubMeddocument of 2 observations

10 percentage_pointsAt the population level, the coverage of HIV testing among pregnant women in Nigeria increased by 10 percentage points from 32.8% to 42.7% between 2013 and 2017.

NigeriaVIH/sidaobserved 2013 to 2017published 2021Journal of public health (Oxford, England)PubMeddocument of 3 observations

5.1 %Out of 2,018,082 persons tested for HIV, 102,165 (5.1%) tested HIV-positive in Akwa Ibom State, Nigeria from April 2017 to March 2021.

NigeriaVIH/sidaobserved April 2017 to March 2021published 2022PloS onePubMeddocument of 7 observations

47 %Among 4072 participants, 47% reported living with HIV.

NigeriaVIH/sidaobserved 2021published 2023BMC public healthPubMeddocument of 13 observations

13.1 per_100_person_yearsHIV incidence among transgender women (TGW) in Abuja and Lagos, Nigeria was 13.1 cases per 100 person-years.

NigeriaVIH/sidaobserved 2013 to 2020published 2022Journal of the International AIDS SocietyPubMeddocument of 20 observations

11.2 %The majority of drug-resistant mutations observed conferred resistance to NRTIs (11.2%).

NigeriaVIH/sidaobserved 2018published 2023AIDS (London, England)PubMeddocument of 3 observations

HIV-infected children were associated with significantly worse mean health-related quality of life (QoL) score compared with HIV-non-infected children.

NigeriaVIH/sidapublished 2020West African journal of medicinePubMeddocument of 8 observations

38 yearsAmong 563 patients in a Nigerian cohort of people with HIV newly initiating antiretroviral therapy, the median age was 38 years.

NigeriaVIH/sidapublished 2023International journal of behavioral medicinePubMeddocument of 7 observations

70.9 %Of the 1,342 PLHIV linked to care in NAIIS, 952 (70.9%) were initiated on ART.

NigeriaVIH/sidaobserved 2018published 2021PloS onePubMeddocument of 13 observations

39,000,000 inhabitantsBy 2022, there were an estimated 39 million people living with HIV globally.

NigeriaVIH/sidaobserved 2022published 2025PloS onePubMeddocument of 13 observations

8 %8% of the tuberculosis cases reviewed had unknown HIV status.

Nigeriatuberculose · VIH/sidaobserved 2008 to 2014published 2020Journal of infection and public healthPubMeddocument of 16 observations

1.9 odds_ratioHIV-exposed infants not breastfed had greater odds of a negative HIV result (OR = 1.9) compared to those breastfed in North-Central Nigeria from January 2015 through July 2017.

NigeriaVIH/sidaobserved January 2015 through July 2017published 2019AIDS research and therapyPubMeddocument of 8 observations

78.5 %Among 800 enrolled sexual and gender minorities living with HIV in Nigeria, 78.5% reported ≥95% pill adherence to antiretroviral therapy.

NigeriaVIH/sidapublished 2023Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 5 observations

12.5 %C. glabrata was isolated in 12.5% of the patients.

NigeriaC. glabrata · oral candidiasis · VIH/sidapublished 2026BMC infectious diseasesPubMeddocument of 11 observations

42 %The intervention increased HIV testing by 42% in the first 6-month follow-up period.

NigeriaVIH/sidapublished 2022JAMA network openPubMeddocument of 7 observations

13.6 %The prevalence of cataract among persons living with HIV/AIDS in Osun State, Nigeria was 13.6%.

Nigeriacataract · VIH/sidapublished 2026BMC ophthalmologyPubMeddocument of 9 observations

28.3 per_1000The incidence rate of adverse drug reactions was 28.3 per 1000 person-years of antiretroviral therapy.

NigeriaVIH/sidapublished 2021African health sciencesPubMeddocument of 4 observations

2.6 %La fréquence de la neuropathie motrice et polyradiculoneuropathique chez les personnes vivant avec le VIH au Nigeria était de 2,6 % en 2010.

Nigerianeuropathie motrice · polyradiculoneuropathie · VIH/sidaobserved 2010HAL · Unilimdocument of 747 observations

1,000 NGNThe median maximum amount people living with HIV (PLHIV) on antiretroviral therapy (ART) were willing to pay for antiretroviral drugs (ARVs) was NGN1,000 (USD $2.78), with an interquartile range of NGN500–NGN2,000.

NigeriaVIH/sidaobserved July and August 2019published 2023PloS onePubMeddocument of 9 observations